I am delighted to invite you to join us in a celebration of the life and work of Andy Vinter, founder of Cresset. The meeting, previously postponed due to Covid-19, will deliver scientific content built on the unique and insightful approach that Andy took to molecular modeling throughout his distinguished career from his early days at Wellcome to his pioneering work on the eXtended Electron Distribution (XED) force field, which was foundational in the creation of Cresset.
Since our founding in 2002, Cresset has grown progressively and has now become a global company, with staff of more than 80 and a stellar customer base across multiple industries. All of this is testament to the groundwork laid by Andy in his time with Wellcome, SmithKline Beecham, University of Cambridge, Peptide Therapeutics and then Cresset.
I hope you’re able to join us, either in-person or virtually, not only in celebration of Andy’s work but also his great sense of humor and irrepressible and joyous irreverence!
Rob Scoffin
Chairman & CEO, Cresset
Agenda and links to abstracts
|
Time
(BST)
|
Title |
Presenter |
| 08:30 |
Registration |
|
| 09:00 |
Welcome |
Rob Scoffin
Cresset, UK
|
| 09:15 |
The Molecular Graphics and Modelling Society: Andy Vinter’s Role in Establishing the MGMS |
Steve Maginn
Molecular Graphics and Modelling Society, UK
|
| 09:30 |
A Tribute to Andy Vinter |
Mark Mackey
Cresset, UK
|
| 10:00 |
Application of In Silico Methods to Library Design Exploring Refractory Chemical Space |
Kaz Ikeda
Keio University, Japan
|
| 10:30 |
Break |
| 11:00 |
Elements of Physical Organic, Medicinal and Computational Chemistry Make ‘Bioisostere’ Replacement Exciting Even After so Many Years of Practice in Drug Discovery |
Manoranjan Panda
BMS, India
|
| 11:30 |
Electrostatic Complementarity in Structure-Based Drug Design |
Gianni Chessari
Astex, UK
|
| 12:00 |
Using Cresset Tools to Re-purpose Existing Drugs: RP0217 from In Silico Screen to Human POC |
Arkasubhra Ghosh
Narayana Nethralaya Foundation, India
Rob Scoffin
Cresset, UK
|
| 12:30 |
Lunch |
| 13:45 |
'Fit for Purpose' Chemistry Technology Development in Pharmaceutical R&D |
Stevan Djuric
Discovery Chemistry and Technology Consulting LLC, USA
|
| 14:15 |
To be confirmed |
Caroline Low
Isomorphic Laboratories, UK
|
| 14:45 |
An Exile on Main Street, Cambridge MA |
Lewis Whitehead
1910 Genetics, USA
|
| 15:15 |
Break |
| 15:45 |
Tailored Modeling Support for Small Molecule Drug Design |
Ingo Mügge
Alkermes, USA
|
| 16:15 |
Exploring Intermolecular Interactions in Structural Databases |
Jason Cole
Cambridge Crystallographic Data Centre, UK
|
| 16:45 |
The Open Force Field Initiative: An Open Source, Open Science Approach to Better Biomolecular Force Fields |
John Chodera
Memorial Sloan-Kettering Cancer Center, USA
|
| 17:15 |
Closing remarks |
Rob Scoffin
Cresset, UK
|
| 17:30 |
Drinks reception |
By invitation |
| 18:30 |
Dinner |
Location
The Møller Institute, Churchill College, Storey’s Way, Cambridge, CB3 0DE, UK.